Skip to main content
. 2022 Jul 18;131(1):116–124. doi: 10.1111/bju.15842

Table 1.

Baseline characteristics.

CON group (n = 10) EX group (n = 20)
Age, years, median (IQR) 68 (61; 70) 63 (57; 67)
Gleason score, n/N (%)
<7 2/10 6/20 (30)
7 6/10 12/20 (60)
>7 2/10 2/20 (10)
PSA level, μg/L, median (IQR) 9.1 (8.4; 18.0) 7.4 (5.4; 13.0)
Body composition
BMI, kg/m2, median (IQR) 27 (24; 30) 27 (25; 29)
Total fat percentage, mean (SD) 28.5 (6.7) 29.3 (6.1)
Total fat mass, kg, mean (SD) 23.6 (8.0) 24.4 (6.1)
Android fat mass, kg, mean (SD) 2.8 (1.2) 2.8 (0.9)
Gynoid fat mass, kg, mean (SD) 3.6 (1.0) 3.6 (0.8)
Lean body mass, kg, mean (SD) 57.3 (6.4) 58.3 (5.9)
Smoker, n (%)
Never 5/10 9/20 (45)
Previous 3/10 9/20 (45)
Current 2/10 2/20 (10)
Alcohol intake (units/week), n (%)
≤14 9/10 16/20 (80)
>14 1/10 4/20 (20)
Physical activity level (min MVPA/week), n (%)
<150 min 3/10 2/20 (10)
≥150 min 7/10 18/20 (90)
Cardiorespiratory fitness*
VO2peak, L/min, mean (SD) 2.62 (0.59) 2.89 (0.50)
VO2peak, mL/min/kg, mean (SD) 31.4 (8.4) 33.6 (6.3)
NK cell infiltration, mean (SD)
NK cells/mm2, tumour tissue 1.05 (1.37) 1.51 (1.85)
NK cells/mm2, healthy tissue 4.15 (4.50) 2.37 (3.33)

Values are presented as mean (SD), median (IQR [Q1; Q3]), or n/N (%).

BMI, body mass index; MVPA, moderate to vigorous physical activity.

*

Cardiorespiratory fitness data are based on cardiorespiratory tests meeting two of the following test criteria: respiratory exchange ratio (RER) ≥1.10, rate of perceived exertion (RPE) ≥18, and a VO2 plateau (EX, n = 18; CON, n = 8).